Physicians Prefer Extended-Release Monotherapy for Treating Patients with ADHD
Extended-release medication for ADHD is preferred by physicians, given its duration of effect and lower number of adverse events.
Stay updated with breaking news from Lightspeed Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Extended-release medication for ADHD is preferred by physicians, given its duration of effect and lower number of adverse events.
Extended-release medication for ADHD is preferred by physicians, given its duration of effect and lower number of adverse events.
Previously worked at AWS for the last six years.
An opportunity for organizations local to WUNC to support the station.
Ogilvy has this week launched its Sustainability Practice in Australia, as brands and business face increasing pressure to clearly communicate environmental social and governance (ESG) goals and progress. The new Sustainability Practice brings together a team of experts from Ogilvy PR, Ogilvy